Uridine triacetate amorphous formulation

LT4284341TActive Publication Date: 2026-07-10PHARMA CINQ LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
LT4284341P0
Authority / Receiving Office
LT · LT
Patent Type
Patents
Current Assignee / Owner
Priority Date
2022-01-27
Filing Date
2022-01-27
Publication Date
2026-07-10
Estimated Expiration
2042-01-27
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.